Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 4, 2013, Pages

  Austin, Nicola ^a   Mcguire, William ^b  

^a Christchurch Womens Hospital   (New Zealand)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; PLACEBO; FLUCONAZOLE;

ANAPHYLAXIS; ANTIFUNGAL THERAPY; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; INFANT; INFANT MORTALITY; INFECTION PREVENTION; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RASH; REVIEW; SEIZURE; SELF ESTEEM; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; THROMBOPHLEBITIS; VERY LOW BIRTH WEIGHT; DEVELOPMENTAL DISORDER; MORTALITY; MYCOSIS; NEWBORN; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIFUNGAL AGENTS; DEVELOPMENTAL DISABILITIES; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MYCOSES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84886852628     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003850.pub4     Document Type: Review

References (62)

1. Arrieta AC, Shea K, Dhar V, Cleary JP, Kukreja S, Morris M, et al.Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study. Clinical Therapeutics 2010;32(2):265-71. [PUBMED: 20206784].
2. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, et al.Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(3):F164-8. [PUBMED: 20659937].
3. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, et al.Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Archives of Disease in Childhood 2011;96(3):F164-8. [PUBMED: 20659937].
4. Cabrera C, Frank M, Carter D, Bhatia J. Fluconazole prophylaxis against systemic candidiasis after colonization: a randomized, double-blinded study. Journal of Perinatology 2002;22:604.
5. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. New England Journal of Medicine 2001;345(23):1660-6.
6. Kaufman D, Boyle R, Hazen KC, Robinson M, Donowitz LG. Effectiveness of fluconazole prophylaxis in the prevention of colonization and invasive infection in preterm infants (Pediatric Academic Societies, Abstract). Pediatric Research 2001;50:309A.
7. Kaufman D, Boyle R, Robinson M, Grossman LB. Long-term safety of intravenous prophylactic fluconazole use in preterm infants less than 1000 grams (Pediatric Academic Societies, Abstract). Pediatric Research 2003;53:2735.
8. Kaufman DA, Cuff AL, Wamstad JB, Boyle R, Gurka MJ, Grossman LB, et al.Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. The Journal of Pediatrics 2011;158(5):759-65.e1.
9. Kaufman D, Boyle R, Hazen K, Patrie J, Robinson M, Grossman LB. Twice weekly fluconazole for prophylaxis for prevention of invasive fungal infection in high-risk infants of <1000g birthweight. The Journal of Pediatrics 2005;147(2):172-9.
10. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107(2):293-8.
11. Kicklighter SD, Springer SC, Phaller MA, Messer S, Cox T, Hulsey TC, et al.Fluconazole for prophylaxis against fungal rectal colonization in the very low birth weight infant (Abstract). Pediatric Research 2000;47:342A.
12. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, et al.A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. New England Journal of Medicine 2007;356(24):2483-95.
13. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, et al.A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. New England Journal of Medicine 2007;356(24):2483-95.
14. Parikh TB, Nanavati RN, Patankar CV, Rao S, Bisure K, Udani RH, et al.Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatrics 2007;44(11):830-7.
15. Violaris K, Carbone T, Bateman D, Olawepo O, Doraiswamy B, LaCorte M. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. American Journal of Perinatology 2010;27(1):73-8. [PUBMED: 19504425].
16. Violaris K, Doraiswamy B, Olawepo O, Gulrajani-LaCorte M. Fluconazole versus nystatin prophylaxis for fungal infection in very low birth weight (VLBW) infants (Abstract). Pediatric Research 1998;44:254A.
17. Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N, et al.Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. Journal of Perinatology 2006;26(9):550-5.
18. Al Qurashi MA, Alallah J, Salma EB, et al.Fluconazole prophylaxis is effective in reducing systemic fungal infection in VLBW infants. A single center four years retrospective study (Abstract). Pediatric Research. 2008; Vol. 63.
19. Aziz M, Patel AL, Losavio J, Iyengar A, Berven M, Schloemer N, et al.Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. The Pediatric Infectious Disease Journal 2010;29(4):352-6. [PUBMED: 19934791].
20. Bertini B, Perugi S, Dani C, Filipp L, Pratesi S, Rubaltelli F. Fluconazole prophylaxis prevents invasive fungal infection in high-risk very low birthweight infants. The Journal of Pediatrics 2005;147(2):162-5.
21. Dutta S, Murki S, Varma S, Narang A, Chakrabarti A. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. Indian Pediatrics 2005;42(12):1226-30.
22. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. The Journal of Pediatrics 2005;147(2):166-71.
23. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 2008;121(4):703-10. [PUBMED: 18381534].
24. Kim MR, Chavda C, Jha V, et al.Prophylactic fluconazole for very low birth weight infants colonised with Candida (Abstract). Pediatric Research. 2008; Vol. 62.
25. Manzoni P, Agrisio R, Mostert M, Leonessa M, Farina D, Latino M, Gomirato G. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year retrospective cohort study. The Journal of Pediatrics 2006;117(1):e22-e32.
26. Manzoni P, Leonessa M, Galletto P, Latino MA, Arisio R, Maule M, et al.Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. The Pediatric Infectious Disease Journal 2008;27(8):731-7. [PUBMED: 18600191].
27. McCrossan BA, McHenry E, O'Neill F, Ong G, Sweet DG. Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Archives of Disease in Childhood. Fetal and Neonatal Edition 2007;92(6):F454-8. [PUBMED: 17460023].
28. Rueda K, Moreno MT, Espinosa M, Saez-Llorens X. Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country. The Pediatric Infectious Disease Journal 2010;29(11):1050-2. [PUBMED: 20571460].
29. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L, et al.Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 2006;117(4):1243-52.
30. Wadhawan R, Dumois J, Escoto D, et al.Near elimination of Candida sepsis after fluconazole prophylaxis in ELBW infants-experience from a tertiary level NICU. Pediatric Research. 2007; Vol. 62.
31. Weitkamp JH, Ozdas A, LaFleur B, Potts AL. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. Journal of Perinatology 2008;28(6):405-11. [PUBMED: 18185518].
32. Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight. Ongoing study 2009.
33. Austin N, Darlow BA, McGuire W. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD003478.pub3].
34. Benjamin DK Jr, Poole C, Steibach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112(3 Pt 1):634-40.
35. Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al.Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117(1):84-92.
36. Brecht M, Clerihew L, McGuire W. Prevention and treatment of invasive fungal infection in very low birthweight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2009;94(1):F65-9. [PUBMED: 18838467].
37. Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis: Systematic review. Journal of Infection 2007;54(6):521-9.
38. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 2006;118(4):e1019-26.
39. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Archives of Disease in Childhood 2006;91(3):F188-92.
40. Clerihew L, McGuire W. Antifungal prophylaxis for very low birthweight infants: UK national survey. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008;93(3):F198-200.
41. Friedman S, Richardson SE, Jacobs SE, O'Brien K. Systemic candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. The Pediatric Infectious Disease Journal 2000;19(6):499-504.
42. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, et al.Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002;110(1 Pt 1):143-51.
43. Huang YC, Li CC, Lin TY. Association of fungal colonization and invasive disease in very low birth weight infants. The Pediatric Infectious Disease Journal 1998;17(9):819-22.
44. Huttova M, Hartmanova I, Kralinsky K, Filka J, Uher J, Kurak J, et al.Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. The Pediatric Infectious Disease Journal 1998;17(11):1012-5.
45. Kaguelidou F, Pandolfini C, Manzoni P, Choonara I, Bonati M, Jacqz-Aigrain E. European survey on the use of prophylactic fluconazole in neonatal intensive care units. European Journal of Pediatrics 2012;171(3):439-45. [PUBMED: 21912893].
46. Karlowicz MG, Rowen JL, Barnes-Eley ML, Burke BL, Lawson ML, Bendel CM, et al.The role of birth weight and gestational age in distinguishing extremely low birth weight infants at high risk of developing candidemia from infants at low risk: a multicenter study. Pediatric Research 2002;51:301A.
47. Kaufman DA, Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clinics in Perinatology 2010;37(3):611-28. [PUBMED: 20813274].
48. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. The Pediatric Infectious Disease Journal 1998;17(6):504-8.
49. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109(1):34-9.
50. Neely MN, Schreiber JR. Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time. Pediatrics 2001;107(2):404-5.
51. O'Grady MJ, Dempsey EM. Antifungal prophylaxis for the prevention of neonatal candidiasis?. Acta Paediatrica 2008;97(4):430-3. [PUBMED: 18363952].
52. Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990;33(1):20-3.
53. Robinson JL, Davies HD, Barton M, O'Brien K, Simpson K, Asztalos E, et al.Characteristics and outcome of infants with candiduria in neonatal intensive care - a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. BMC Infectious Diseases 2009;9:183. [PUBMED: 19930662].
54. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al.Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. The Pediatric Infectious Disease Journal 2000;19(4):319-24.
55. Sarvikivi E, Lyytikäinen O, Soll DR, Pujol C, Pfaller MA, Richardson M, et al.Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. Journal of Clinical Microbiology 2005;43(6):2729-35.
56. Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. The Journal of Pediatrics 2003;142(5):564-5.
57. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al.Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal of Pediatrics 1996;129(1):63-71.
58. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al.Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91.
59. Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, et al.Neonatal infections in England: the NeonIN surveillance network. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(1):F9-14. [PUBMED: 20876594].
60. Wynn JL, Tan S, Gantz MG, Das A, Goldberg RN, Adams-Chapman I, et al.Outcomes following candiduria in extremely low birth weight infants. Clinical Infectious Diseases 2012;54(3):331-9. [PUBMED: 22144537].
61. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 4, Issue 2007 10.1002/14651858.CD003850.pub3. [DOI: 10.1002/14651858.CD003850.pub3].
62. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003850.pub2].